Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8733676 | Critical Reviews in Oncology/Hematology | 2018 | 14 Pages |
Abstract
This paper sets out to review all experimental and theoretical comparisons of efficacy and therapeutic gain for alpha and beta emitters labelling the same targeting vector. The overall conclusion is that targeted alpha therapy is superior to targeted beta therapy, such that the use of alpha therapy in clinical settings should be expanded.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Loredana Marcu, Eva Bezak, Barry J. Allen,